ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350629; 2) Community: the network communities that were significantly associated with the response to NSC 350629; 3) Molecule: the relationships between components within communities and NSC 350629; 4) MDR: the compounds that were significantly associated with the NSC 350629.

NSC Compound Enrichment Correlation
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.000100665759440623 0.60422863
NSC 632877 Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) 0.000115730130665038 0.86526818
NSC 624902 Null 0.000125296947977996 0.59360819
NSC 628572 Null 0.000143065913599157 0.6485949
NSC 648322 Incarnal 0.000143065913599157 0.87330038
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.000143065913599157 0.82563
NSC 664951 Null 0.000143065913599157 0.86409377
NSC 618201 1,4-Anthracenedione, 5-hydroxy- 0.000155853121040032 0.84604616
NSC 621339 Null 0.000155853121040032 0.58706183
NSC 645777 STREPTOMYCES ANTIBIOTIC DC-107 0.000155853121040032 0.74261797
Total:116  Current:1    [First] [Prev] [Next] [Last]